--2024/Q4-- / 201.670K--
--2024/Q3-- / 168.330K--
Aug 8, 20242024/Q2104.000K / 312.370K--
May 15, 20242024/Q1176.000K / 350.000K--
--2023/Q4314.000K / 316.670K--
US Stock MarketDetailed Quotes
OCX OncoCyte
- 2.9000
- -0.1000-3.33%
Trading Nov 4 15:12 ET
48.82MMarket Cap-683P/E (TTM)
2.9600High2.9000Low15.81KVolume2.9900Open3.0000Pre Close46.36KTurnover0.23%Turnover RatioLossP/E (Static)16.84MShares4.340052wk High2.15P/B19.83MFloat Cap2.285052wk Low--Dividend TTM6.84MShs Float204.8000Historical High--Div YieldTTM2.00%Amplitude2.0800Historical Low2.9320Avg Price1Lot Size
OncoCyte Key Stats
OncoCyte Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
OncoCyte Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data